Syntax Bio
Develops cell therapies using proprietary Cellgorithm platform for regenerative medicine
$14.4MSeries A+
Role not disclosedIV
Illumina Ventures
Activity from announced rounds
Activity in this selectiona16z-bio-health-1883279d
- Rounds participated in
- 3
- Confirmed lead rounds
- — 3 roles undisclosed
- New companies
- 3 First participation on record · 0 follow-on
- Funding in participating rounds
- $166.4M 3 disclosed · full round size, not this investor’s share